1. Company is a well-known pharmaceutical circulation enterprise at home and abroad, and its scale is second to none in China. Its annual sales of the first pharmacy in Shanghai ranked first in the national single retail pharmacy for many years. The company has a pharmaceutical retail network of 65,438+0,065,438+0, covering 65,438+06 districts and counties in Shanghai. Some high-quality assets are selected from more than 65,438+0 franchise chain stores in various provinces and cities across the country. In the reform of Shanghai's medical system, seven pharmacies under the company, including the first pharmacy, Lingling pharmacy and Boshan pharmacy, were designated as Shanghai medical insurance pharmacies.
2. Main financial indicators of the company in the first three quarters of 2009: earnings per share of 0.2055 yuan, net assets per share of 2.4400 yuan, return on net assets of 8.4400%, and operating income of 789,298,492.4500 yuan, up or down10.0582% year-on-year; The net profit attributable to shareholders of listed companies was 32,747,075.49 yuan, up or down by 65,438+065,438+04.1435% year-on-year.
3. The company's profit distribution plan for 2008 is: 0.70 yuan per 10 share (including tax). Date of filing: August 2009 13; Ex-dividend date: August 2009 14; Cash dividend payment date: August 20, 2009.